NICE has recommended regular NHS funding for Roche's Ocrevus, although there are still restrictions on its use.
We both now have hope - MS sisters - BBC News
Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS | MS Trust
Alastair Stewart on Twitter: "On @itvnews at 1:30pm,a huge break-through for suffers of MS. We talk to one of them and the charity @mssociety, who are celebrating."
Dan Rodricks on Twitter: "WJZ responded out of fear, managing to both overreact and underreact at the same time. It was a sad moment for journalism, on top of Ms. Bubala’s phrasing, and a missed opportunity to further a crucial conversation. @triciabishop @baltsunopinion https://t.co/aml0jYmwd9"
Dario Pizzano on Twitter: "My first online contest with ms_4_ms has officially come to a close!
We had over 50 entries and we reached over 1,000 people as we continue spreading awareness of Multiple Sclerosis in support of all the… https://t.co/vbRbe5PxEa"
Geoff Regan on Twitter: "I had a great discussion w/ the wonderful folks from the @MSAtlantic Society, a cause that is dear to me, having seen the impact of #MultipleSclerosis on relatives and friends. For anyone seeking support with #MS, #MSNavigators is a great support resource: https://t.co/ESp5lBFtal… https://t.co/pTsQTfapz8"
Health watchdog approves first ever treatment for progressive form of MS in massive U-turn | Daily Mail Online
Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years